These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10469004)

  • 1. Toward better treatment of congenital adrenal hyperplasia.
    Speiser PW
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):273-4. PubMed ID: 10469004
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of carbenoxolone on the plasma renin activity and hypothalamic-pituitary-adrenal axis in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Irony I; Cutler GB
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):285-91. PubMed ID: 10469007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbenoxolone effects in congenital adrenal hyperplasia.
    Walker BR; Stewart PM
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):246-8. PubMed ID: 10671957
    [No Abstract]   [Full Text] [Related]  

  • 4. Requirement of mineralocorticoid in congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency.
    Hochberg Z; Benderly A; Kahana L; Zadik Z
    J Clin Endocrinol Metab; 1986 Jul; 63(1):36-40. PubMed ID: 3011843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of cortisone acetate treatment in congenital adrenal hyperplasia because of defective 11beta-hydroxysteroid dehydrogenase reductase activity.
    Nordenström A; Marcus C; Axelson M; Wedell A; Ritzén EM
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1210-3. PubMed ID: 10199755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquorice, growth retardation and Addison's disease.
    Doeker BM; Andler W
    Horm Res; 1999; 52(5):253-5. PubMed ID: 10844416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early hypertension and prolonged mineralocorticoid therapy discontinuation in a child with salt-wasting 21-hydroxylase deficiency.
    Wasniewska M; Valenzise M; Aversa T; Mirabelli S; De Luca F; De Luca FL; Lombardo F
    J Endocrinol Invest; 2011 Feb; 34(2):159-61. PubMed ID: 21502797
    [No Abstract]   [Full Text] [Related]  

  • 8. [Adrenogenital syndrome].
    Fujieda K
    Nihon Rinsho; 2006 Jun; Suppl 2():643-6. PubMed ID: 16817483
    [No Abstract]   [Full Text] [Related]  

  • 9. Licorice, computer-based analyses of dehydrogenase sequences, and the regulation of steroid and prostaglandin action.
    Baker ME; Fanestil DD
    Mol Cell Endocrinol; 1991 Jun; 78(1-2):C99-102. PubMed ID: 1834493
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes.
    Andrews RC; Rooyackers O; Walker BR
    J Clin Endocrinol Metab; 2003 Jan; 88(1):285-91. PubMed ID: 12519867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal inactivation, mineralocorticoid generation, and 11beta-hydroxysteroid dehydrogenase inhibition ameliorate the antimineralocorticoid effect of progesterone in vivo.
    Quinkler M; Meyer B; Oelkers W; Diederich S
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3767-72. PubMed ID: 12915667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Somatic development in a group of 59 children with congenital adrenal hyperplasia in relation to therapy].
    Lisá L
    Cesk Pediatr; 1989 Dec; 44(12):712-3. PubMed ID: 2636554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of carbenoxolone on the peripheral metabolism of cortisol in human patients.
    Ulick S; Wang JZ; Hanukoglu A; Rösler A
    J Lab Clin Med; 1993 Dec; 122(6):673-6. PubMed ID: 8245686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital adrenal hyperplasia.
    Speiser PW; White PC
    N Engl J Med; 2003 Aug; 349(8):776-88. PubMed ID: 12930931
    [No Abstract]   [Full Text] [Related]  

  • 15. New approaches to the treatment of congenital adrenal hyperplasia.
    Merke DP; Cutler GB
    JAMA; 1997 Apr; 277(13):1073-6. PubMed ID: 9091697
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lipoid adrenal hyperplasia].
    Fujieda K
    Nihon Rinsho; 2006 May; Suppl 1():692-5. PubMed ID: 16776250
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of renal 11beta-hydroxysteroid dehydrogenase in vivo by carbenoxolone in the rat and its relationship to sodium excretion.
    Sewell KJ; Shirley DG; Michael AE; Thompson A; Norgate DP; Unwin RJ
    Clin Sci (Lond); 1998 Oct; 95(4):435-43. PubMed ID: 9748419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortisol as mineralocorticoid.
    Ulick S
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1307-8. PubMed ID: 8636321
    [No Abstract]   [Full Text] [Related]  

  • 19. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age.
    Stewart PM; Wallace AM; Valentino R; Burt D; Shackleton CH; Edwards CR
    Lancet; 1987 Oct; 2(8563):821-4. PubMed ID: 2889032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3Beta-hydroxysteroid dehydrogenase deficiency].
    Goto Y; Yanase T
    Nihon Rinsho; 2006 May; Suppl 1():685-8. PubMed ID: 16776248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.